ÂÜÀòÂÒÂ×

Reinhard Ambros PhD is an experienced board member in the biotech and pharmaceutical sectors, currently serving on the Board of Directors for multiple companies including Genedata, Viridos, Aileron Therapeutics, TruDataRx, and ImmunOs Therapeutics AG, where Reinhard also holds the position of Chairman of the Board. Previously, Reinhard Ambros was influential at Novartis, leading the Novartis Venture Funds and shaping the company's group strategy. With a strong academic background that includes a PhD in Medicinal and Pharmaceutical Chemistry from the University of Regensburg, along with postdoctoral work in Pharmacology and Chemistry, Reinhard Ambros combines expertise in research and corporate strategy in the life sciences domain.